Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-21 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.370 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SBTX | Silverback Therapeutics | 0.5% | 982.9M |
Silverback Therapeutics Company Questions & Answers
Q
How do I buy Silverback Therapeutics (SBTX) stock?
A
You can purchase shares of Silverback Therapeutics (NASDAQ: SBTX) through any online brokerage.
Q
Who are Silverback Therapeutics's (SBTX) main competitors?
A
There are no as such competitors for Silverback Therapeutics.
Q
What is the target price for Silverback Therapeutics?
A
The latest price target for Silverback Therapeutics (NASDAQ: SBTX) was reported by SVB Leerink on 2021-04-06. The analyst firm set a price target for 49.00 expecting SBTX to rise to within 12 months (a possible 74.01% upside). 5 analyst firms have reported ratings in the last year.
Q
How much is Silverback Therapeutics (SBTX) stock ?
A
The stock price for Silverback Therapeutics (NASDAQ: SBTX) is $28.16 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
Q
When is the next Silverback Therapeutics (SBTX) dividend?
A
There are no upcoming dividends for Silverback Therapeutics.
Q
When is Silverback Therapeutics (NASDAQ:SBTX) reporting earnings?
A
Silverback Therapeutics’s Q2 earnings are confirmed after-market from now on August 4, 2021.
Q
When is the upcoming split for SBTX?
A
There is no upcoming split for Silverback Therapeutics.